Literature DB >> 8327852

Peroxisomal beta-oxidation of polyunsaturated long chain fatty acids in human fibroblasts. The polyunsaturated and the saturated long chain fatty acids are retroconverted by the same acyl-CoA oxidase.

E Christensen1, B Woldseth, T A Hagve, B T Poll-The, R J Wanders, H Sprecher, O Stokke, B O Christophersen.   

Abstract

The metabolism of the C22 unsaturated fatty acids erucic acid (22:1(n-9)), adrenic acid (22:4(n-6)), docosapentaenoic acid (22:5(n-3)) and docosahexaenoic acid (22:6(n-3)) was studied in cultured fibroblasts from patients with acyl-CoA oxidase deficiency, the Zellweger syndrome, X-linked adrenoleukodystrophy (X-ALD) and normal controls. [3-14C] 22:4 (n-6) and [3-14C] 22:5 (n-3) were shortened (retroconverted) to [1-14C] 20:4 (n-6) and [1-14C] 20:5 (n-3), respectively, in normal and X-ALD fibroblasts. In Zellweger and acyl-CoA oxidase deficient fibroblasts these reactions were deficient. Since the retroconversion is normal in X-ALD fibroblasts peroxisomal very long chain (lignoceryl) CoA ligase is probably not required for the activation of C22 unsaturated fatty acids. The present work with fibroblasts from patients with a specific acyl-CoA oxidase deficiency, previously shown to have a deficient peroxisomal clofibrate-inducible acyl-CoA oxidase, and which accumulate 24:0 and 26:0 fatty acids, supports the view that this enzyme is responsible for the chain-shortening of docosahexaenoic acid (22:6(n-3)), erucic acid (22:1(n-9)), docosapentaenoic acid (22:5(n-3)), and adrenic acid (22:4(n-6)) as well.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8327852     DOI: 10.3109/00365519309090698

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  13 in total

1.  A short-term n-3 DPA supplementation study in humans.

Authors:  Eliza Miller; Gunveen Kaur; Amy Larsen; Su Peng Loh; Kaisa Linderborg; Harrison S Weisinger; Giovanni M Turchini; David Cameron-Smith; Andrew J Sinclair
Journal:  Eur J Nutr       Date:  2012-06-23       Impact factor: 5.614

2.  Docosahexaenoic acid is both a product of and a precursor to tetracosahexaenoic acid in the rat.

Authors:  Adam H Metherel; R J Scott Lacombe; Raphaël Chouinard-Watkins; Richard P Bazinet
Journal:  J Lipid Res       Date:  2018-12-20       Impact factor: 5.922

Review 3.  Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.

Authors:  Martin-Paul Agbaga; Md Nawajes A Mandal; Robert E Anderson
Journal:  J Lipid Res       Date:  2010-03-18       Impact factor: 5.922

4.  Regulation of the biosynthesis of 4,7,10,13,16-docosapentaenoic acid.

Authors:  B S Mohammed; D L Luthria; S P Bakousheva; H Sprecher
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

5.  Serum n-3 Tetracosapentaenoic Acid and Tetracosahexaenoic Acid Increase Following Higher Dietary α-Linolenic Acid but not Docosahexaenoic Acid.

Authors:  Adam H Metherel; Anthony F Domenichiello; Alex P Kitson; Yu-Hong Lin; Richard P Bazinet
Journal:  Lipids       Date:  2016-12-22       Impact factor: 1.880

6.  The questionable role of a microsomal delta8 acyl-coA-dependent desaturase in the biosynthesis of polyunsaturated fatty acids.

Authors:  Q Chen; F Q Yin; H Sprecher
Journal:  Lipids       Date:  2000-08       Impact factor: 1.880

7.  N-3 and n-6 fatty acid metabolism in undifferentiated and differentiated human intestine cell line (Caco-2).

Authors:  Y S Huang; J W Liu; K Koba; S N Anderson
Journal:  Mol Cell Biochem       Date:  1995-10-18       Impact factor: 3.396

Review 8.  Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: a complex intracellular process.

Authors:  H Sprecher; Q Chen; F Q Yin
Journal:  Lipids       Date:  1999       Impact factor: 1.646

Review 9.  A review of the biologic and pharmacologic role of docosapentaenoic acid n-3.

Authors:  Puya G Yazdi
Journal:  F1000Res       Date:  2013-11-25

Review 10.  Disease monitoring of hepatocellular carcinoma through metabolomics.

Authors:  Asem I Fitian; Roniel Cabrera
Journal:  World J Hepatol       Date:  2017-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.